Impact of pharmacists on outcomes for patients with psychiatric or neurologic disorders.

Werremeyer, Amy; Bostwick, Jolene; Cobb, Carla; Moore, Tera D; Park, Susie H; Price, Cristofer; McKee, Jerry

Werremeyer, Amy; Bostwick, Jolene; Cobb, Carla; Moore, Tera D; Park, Susie H; Price, Cristofer; McKee, Jerry.

Afiliación

Werremeyer A; Associate Professor, School of Pharmacy, North Dakota State University, Fargo, North Dakota, amy.werremeyer@ndsu.edu.
Bostwick J; Clinical Professor and Associate Chair, University of Michigan College of Pharmacy, Ann Arbor, Michigan.
Cobb C; Owner and Consultant, Capita Consulting, Billings, Montana.
Moore TD; National Pharmacy Benefits Management Program Manager, Clinical Practice Integration and Model Advancement, Clinical Pharmacy Practice Office, Pharmacy Benefits Management Services, US Department of Veterans Affairs, Washington, DC.
Park SH; Associate Professor, School of Pharmacy, University of Southern California, Los Angeles, California.
Price C; Clinical Pharmacy Program Manager - Mental Health, Providence Veterans Affairs Medical Center, Providence, Rhode Island.
McKee J; CEO and Lead Consultant, Psychopharm Solutions LLC, Morganton, North Carolina.

Ment Health Clin ; 10(6): 358-380, 2020 Nov.

Article en En | MEDLINE | ID: mdl-33224694

Palabras clave

interprofessional team; medication management; neurologic pharmacist; patient-level outcomes; psychiatric pharmacist

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Systematic_reviews Idioma: En Revista: Ment Health Clin Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google